World Vaccine Congress Washington 2010

Quick links

networking & contacts

NEW IN 2010

	H1N1 Federal Planning and Industry Response
	Innovation in Key Markets: Pneumococcal, Meningococcal and HPV
	"BRICS" and Mortar: Building sustainable emerging vaccine markets
	The Rise of Therapeutics
	Market M&A: What's next
	Cell Based Production - The New Frontier
	Redesigned "Contact" - your online networking partner
	Dedicated 1-2-1 meeting area
	Over 20 hours of decicated networking

World Vaccine Congress Washington
Celebrating a decade as North America's leading vaccine event

NEW ARRIVALS - Dr Philip Ferro, Chief of Portfolio Management, ASPR, BARDA, US DHHS and Noel Barrett, Vice President, Research & Development, Vaccines, Baxter BioScience join the 2010 faculty

Now in its 10th year, World Vaccine Congress 2010 remains the industry’s definitive vaccine industry event for major vaccine players and their respective senior level representatives.

>> Download the brochure

>> Register now

Officially the longest-running and largest vaccine industry event in North America, World Vaccine
Congress continues to deliver a forum where the ever-changing dynamics of an industry in resurgence are discussed and acted upon by the industry’s most senior figures.

Over four days you can be confident that you will meet the World’s most compelling and influential scientific and strategic leaders, facilitating education, debate and business.

Key issues to be addressed

How is government drawing parallels between Health Care reform, public health preparedness and vaccines?
How will priority setting in the National Vaccine Plan impact future industry vaccine programmes
How are Big Pharma strategising future vaccine research and commercialisation efforts?
How are non-traditional "BRIC" markets helping shape a truly globalised vaccine industry?
How are Federal and industry approaches to H1N1 meeting demand? What is still required?
How are the big 7 vaccine markets shaping up? Where are there still opportunities for growth?
How can industry secure long-term expansion through emerging market presence and partners?
How can traditional intra-market strategic collaborations offer up novel and complimentary growth?
How can vaccine approval and licensure be obtained in an ever evolving regulatory framework?
How are technological advances impacting R&D and advancing product development timelines?

Your best chance to do vaccine business across the globe!

As a sponsor, you are offered an unrivalled opportunity to:

Position yourself as an industry leader at the most prestigious meeting place of the year
Have exclusive access to the most senior decision-makers in the industry
Meet the industry leaders, understand their needs better, and develop business relationships

Get cost-effective marketing exposure and branding to your target audience, culminating in
face-to-face meetings with your best prospects

» Find out more about sponsorship

Who should sponsor?

The following sectors typically sponsor and exhibit at the world’s premier meeting place for the vaccine industry:

Venture Capitalists
Investment Banks
CSOs
Equipment Providers
Delivery technology manufacturers
Vaccine Technology Platforms
Regional Development Agencies
Biotechs
Consultants
Packaging/Cold Chain and Logistics
Law Firms

» Find out more about sponsorship

NETWORK WITH 120+ SPEAKERS INCLUDING:

	DR NICOLE LURIE Assistant Secretary, Office of ASPR, Office of the Secretary US DHHS		CAPT RAY STRIKAS Medical Officer, National Vaccine Program Office, US DHHS		DR VAS NARASIMHAN CEO North America and President Vaccines USA, Novartis Vaccines and Diagnostics
	DR MONIQUE MANSOURA Director of Policy, Planning and Requirements, BARDA, ASPR, US Department of Health and Human Services DR GERALD KOVACS Director, Division of CBRN Countermeasures, BARDA, OSPR, US DHHS DR MICHAEL PERDUE Director, Influenza and Emerging Diseases, Biomedical Advanced Research and Development Authority, Office of the Assistant Secretary for Preparedness & Response, Office of the Secretary, US DHHS DR MICHAEL KURILLA Director, Office of Biodefense Research Activities in the Division of Microbiology and Infectious Diseases, Associate Director for Biodefense Product Development, NIAID, NH, US Department of Health and Human Services DR HECTOR IZURIETA Chief, Vaccine Safety Branch, Office of Biostatistics and Epidemiology, CBER, US FDA DR DANIEL SALMON Vaccine Safety Specialist, National Vaccine Programme Office, Office of Public Health and Science, Office of the Secretary, US Department Of Health and Human Services DR JOHN MODLIN Professor and Chair, Department of Pediatrics, Senior Associate Dean for Clinical Affairs, Dartmouth Medical School, Dartmouth Hitchcock Medical Center and Chair, Vaccines and Related Biological Products Advisory Committee, FDA, US DHHS		DR PHILIPPE MONTEYNE Senior Vice President, Head Global Vaccine Development, GlaxoSmithKline Biologicals DR JEFFREY ALMOND Vice President, Discovery and External Research and Development, sanofi pasteur DR ANTHONY FORD- HUTCHINSON Senior Vice President and Franchise Head, Vaccines & Infectious Diseases, Merck Research Laboratories DR DOUGLAS PON Assistant Vice President, Global Business Development, Pfizer Inc DR CLEMENT LEWIN Head, Strategic Immunisation Planning, Novartis Vaccines and Diagnostics ALLAN JARVIS Vice President, Corporate Development, sanofi pasteur DR NATHALIE GARCON Vice President, Head of Global Adjuvant Center for Vaccine Development, GSK Biologicals DR DIANA LANCHONEY Executive Director, Developing World Strategic Integration, Merck Vaccine Division and Infectious Disease, Merck & Co. DR JEFFREY ULMER Global Head of External Research Novartis Vaccines & Diagnostics JEFF SOUTHERTON Executive Director, Worldwide Business Development, Pfizer Global R&D		DR GERD ZETTLMEISSL Chief Executive Officer, Intercell DR J TYLER MARTIN Vice President and Chief Medical Officer, Dynavax DR MARK FROHLICH Chief Medical Officer, Dendreon DR SAMUEL PONCE DE LEON Chief Executive Office, Birmex DR AKIRA HOMMA Chairman, Bio-Manguinhos (Fiocruz) DR SURESH JADHAV Executive Director, Serum Institute of India DR JOSEPH SANTANGELO Chief Operating Officer, SingVax DR ALAN SHAW Chief Executive Officer, VaxInnate DR DANIEL ADAMS Chief Executive Officer, Protein Sciences DR RAHUL SINGHVI Chief Executive Officer, Novavax DR RAAFAT FAHIM Chief Executive Officer, Nabi Pharmaceuticals STAPH BAKALI Chief Executive Officer, Genocea Bioscience

>> See full speaker line-up

event sponsors

Platinum Sponsor:

Gold Sponsors:

.

ViE Awards Sponsor

Silver Sponsor

Associate Sponsors

Event Partner:

Biotech Showcase Sponsor:

>> Full list of sponsors and exhibitors

sponsorship opportunities

Grow your business - sponsorship really works!

Get cost effective marketing exposure and branding to your target audience, culminating in face-to-face meetings with your top prospects

Position yourself as an industry leader

Increase your brand recognition

Create new partnerships and alliances

Showcase products and services to a targeted audience of decision-makers

Target your market!

For details contact
Bindu Jolly